Osmolarity is the Gold Standard for diagnosing and managing Dry Eye Disease. The TearLab Osmolarity System measures osmolarity with a quantitative, objective endpoint. CMS Reimbursement - $46.80 per patient (in the U.S. only). CPT Code 83861QW. FDA 510(k) cleared. CLIA Waived. CE Marked.
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System.